"10.1371_journal.pone.0066955","plos one","2013-07-26T00:00:00Z","Steven M Rowe; Bo Liu; Aubrey Hill; Heather Hathorne; Morty Cohen; John R Beamer; Frank J Accurso; Qunming Dong; Claudia L Ordoñez; Anne J Stone; Eric R Olson; John P Clancy; for the VX06-770-101 Study Group","University of Alabama at Birmingham, Birmingham, Alabama, United States of America; Seattle Childrens Hospital, Seattle, Washington, United States of America; University of Colorado Denver, Aurora, Colorado, United States of America; Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts, United States of America; Cincinnati Childrens Hospital Medical Center and the University of Cincinnati, Cincinnati, Ohio, United States of America","¶ Membership of the VX06-770-101 Study Group is provided in the Acknowledgments.","Several authors on this manuscript are (or were) employees of Vertex Pharmaceuticals (QD, CLO, AJS, and ERO), Drs. JPC, FJA, and SMR were site investigators for the primary study of interest that was funded by Vertex Pharmaceuticals, and Dr. JPC has served as a consultant for Vertex Pharmaceuticals (member of the CF Global Scientific Advisory Board). This does not alter the authors adherence to all of the PLOS ONE policies on sharing data and materials.","2013","07","Steven M Rowe","SMR",13,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
